The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19

Journal of Thrombosis and Thrombolysis · Published 2026-05-18 · DOI 10.1007/s11239-026-03289-1

Authors (4)

Aleksandra Franczak, Paul Calistrate-Petre, Irina Dinu, Paul Jurasz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Franczak, A., Calistrate-Petre, P., Dinu, I., et al. (2026). The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03289-1

Related articles

• Biomarkers, mechanisms, and precision care in thrombosis · Journal of Thrombosis and Thrombolysis · 2026 · Cites or is cited by this article · Same journal
• Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Systemic immune-inflammation index predicts left atrial thrombus in non-valvular atrial fibrillation: A retrospective study of 847 patients · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• A qualitative study of warfarin self-management in the United States healthcare system: insights from patient experiences · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Localized antithrombotic but minimal systemic coagulation effects of sodium bicarbonate in mechanical circulatory support · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Long non-coding RNA NPPA-AS1 acts as a potential novel biomarker and promotes atrial fibrillation progression via the miR-302e/TGFBR2 axis · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Practice patterns of DOAC high-intensity period following parenteral lead-in treatment for venous thromboembolism · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Verification and optimization of the VTE risk stratification system for multiple myeloma · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Antiplatelet effects of oral anticoagulants in patients with atrial fibrillation: ex-vivo studies · Journal of Thrombosis and Thrombolysis · 2026 · Same journal